Doctor-Patient Communication About Colorectal Cancer Screening

The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.

Study Overview

• Status: Completed
• Conditions: Colorectal Cancer Screening
• Intervention / Treatment: Behavioral: surveys

• Study Type: Observational
• Enrollment (Actual): 76

Contacts and Locations

Study Locations

• United States
  • New York
    • Bronx, New York, United States
      • Albert Einstein College Of Medicine
    • Bronx, New York, United States
      • Hhc, Gun Hill and Tremont

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 75 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Five health centers of the NYC RING will participate in this project. All are located in underserved urban communities within the Bronx.

Description

Inclusion Criteria:

Physicians

• Attending physicians or third year residents specializing in internal medicine or family medicine, as per the medical director from the clinic.
• Clinic is based at a NYC RING-affiliated practice.
• English speaking; Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Patients

• Ages 50-75 years old, per the United States Preventive Services Task Force recommendations for screening. This will be determined by a pre-screening of medical records by the RSA.
• Due for colorectal cancer screening at the time of the visit, ascertained through patient self-report (e.g., no colonoscopy within the past 10 years, no flexible sigmoidoscopy or barium enema within the past five years, and no FOBT within the past year).
• Coming for either an annual physical exam or chronic care follow up visit, per patient self-report.
• Planning to consult with the physician in English, per patient self-report. Due to limited resources, we cannot have each audio recorded consultation translated therefore, the consultation needs to be in English.

Exclusion Criteria:

• History of colorectal cancer, per patient self-report or per EMR..
• History of polyps being removed, per patient self-report.
• Colonoscopy scheduled in EMR at time of screening.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Pts having colorectal cancer screening; The target sample of this study will be approximately 200 primary care physician-patient consultations who discuss CRC screening during the course of a clinical visit. Physician and patient participants will come from primary care practices associated with the New York City Research and Improvement Networking Group (NYC RING).	Behavioral: surveys; The intervention will be the audio-recording of the physician-patient consultation, patient and doctor surveys. These audio recordings will be coded. It will also include follow-up phone calls with patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
describe doctor-patient communication about CRC screening	screening adherence through self report. Screening adherence will be assessed by contacting the patients and asking them if they received the CRC screening test their doctor ordered at the audio recorded visit.	2 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes.		2 years
examine the association between the quality of doctor-patient communication about CRC screening and low-income patients' screening outcomes	intent to be screened (immediately after the consultation) using the item from Geller et al.25 and 2) self-efficacy for screening (immediately after consultation) in case there are few events of actual screening.	2 years

Collaborators and Investigators

• Sponsor: Memorial Sloan Kettering Cancer Center
• Collaborators: Albert Einstein College of Medicine; Virginia Commonwealth University; HHC, Gun HIll and Tremont; NYC RING, Director

Publications and helpful links

Helpful Links

• Memorial Sloan Kettering Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): February 7, 2012
• Primary Completion (Actual): December 26, 2019
• Study Completion (Actual): December 26, 2019

Study Registration Dates

• First Submitted: February 10, 2012
• First Submitted That Met QC Criteria: February 14, 2012
• First Posted (Estimate): February 17, 2012

Study Record Updates

• Last Update Posted (Actual): January 2, 2020
• Last Update Submitted That Met QC Criteria: December 31, 2019
• Last Verified: December 1, 2019

More Information

Terms related to this study

• Keywords: questionnaire; survey; Doctor-Patient Communication; 12-017
• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colorectal Neoplasms
• Other Study ID Numbers: 12-017 (Dana-Farber Cancer Institute)